Michael Weintraub Sells 20,565 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) Director Michael Weintraub sold 20,565 shares of the company’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $25.04, for a total transaction of $514,947.60. Following the completion of the sale, the director now directly owns 242,827 shares in the company, valued at approximately $6,080,388.08. The trade was a 7.81 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

Michael Weintraub also recently made the following trade(s):

• On Monday, December 16th, Michael Weintraub sold 861 shares of Phreesia stock. The stock was sold at an average price of $25.26, for a total value of $21,748.86.
• On Monday, December 2nd, Michael Weintraub sold 15,152 shares of Phreesia stock. The shares were sold at an average price of $21.01, for a total value of $318,343.52.

Phreesia Stock Performance

NYSE PHR opened at $24.01 on Thursday. The firm has a 50-day moving average price of $20.66 and a two-hundred day moving average price of $21.90. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $29.16. The company has a market capitalization of $1.40 billion, a P/E ratio of -16.33 and a beta of 0.98. The company has a quick ratio of 1.77, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.58) earnings per share. Analysts anticipate that Phreesia, Inc. will post -1.16 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. International Assets Investment Management LLC raised its stake in Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after purchasing an additional 1,395 shares in the last quarter. nVerses Capital LLC raised its position in shares of Phreesia by 76.5% in the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock valued at $64,000 after buying an additional 1,300 shares in the last quarter. Lombard Odier Asset Management USA Corp bought a new stake in shares of Phreesia during the 2nd quarter worth approximately $202,000. Point72 DIFC Ltd acquired a new stake in shares of Phreesia during the 2nd quarter worth approximately $209,000. Finally, XTX Topco Ltd bought a new position in Phreesia in the third quarter valued at approximately $247,000. Institutional investors own 92.10% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on PHR shares. DA Davidson reiterated a “buy” rating and set a $32.00 target price on shares of Phreesia in a research note on Thursday, September 5th. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a report on Tuesday, December 10th. Canaccord Genuity Group restated a “buy” rating and set a $34.00 target price on shares of Phreesia in a research note on Thursday, September 5th. Truist Financial raised their target price on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.33.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.